Sign in

CIK 0001091596 · Non-accelerated filer<br>Smaller reporting company

Nuo Therapeutics, Inc.

Sign in to watch
Ticker
AURX
Exchange
OTC
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
233011702
Phone
832-236-9060
Business address
8285 EL RIO, SUITE 190, HOUSTON, TX, 77054
Former names
Nuo Therapeutics, Inc, CYTOMEDIX INC, AUTOLOGOUS WOUND THERAPY INC, AUTOLOGOUS WOUND TRERAPY INC
Open-market buys, last 90 days
$9,539
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$9,539. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. JORDEN DAVID EMERSON +$10K CEO/CFO 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2010-06-08 JORDEN DAVID EMERSON Director Purchase +23,100 $0.48 $11K 4,345,100
2010-05-20 JORDEN DAVID EMERSON Director Purchase +16,000 $0.62 $10K 4,322,000
2010-05-18 JORDEN DAVID EMERSON Director Purchase +206,000 $0.63 $130K 4,306,000
2010-04-29 JORDEN DAVID EMERSON Director Purchase +25,000 $0.72 $18K 4,100,000
2010-04-28 JORDEN DAVID EMERSON Director Purchase +14,000 $0.72 $10K 4,075,000
2010-04-16 JORDEN DAVID EMERSON Director Purchase +22,270 $0.59 $13K 4,061,000
2010-04-14 JORDEN DAVID EMERSON Director Purchase +32,310 $0.56 $18K 4,038,730
2010-04-13 JORDEN DAVID EMERSON Director Purchase +100,000 $0.56 $56K 4,006,420
2010-04-13 JORDEN DAVID EMERSON Director Purchase +100,000 $0.56 $56K 4,421,474
2010-04-09 JORDEN DAVID EMERSON Director Purchase · 10% Series D Convertible Preferred Stock +0 473,044
2010-04-09 JORDEN DAVID EMERSON Director Purchase · Common Stock +0 744,726
2010-04-09 Maslan Andrew Scott Chief Financial Officer Purchase · 10% Series D Convertible Stock +0 367,321
2010-04-09 Maslan Andrew Scott Chief Financial Officer Purchase · Common Stock Warrants +0 376,282
2010-04-09 ROSENDALE MARTIN P Chief Executive Officer Purchase · 10% Series D Convertible Preferred Stock +0 926,259
2010-04-09 ROSENDALE MARTIN P Chief Executive Officer Purchase · Common Stock Warrants +0 944,181
2010-04-09 JORDEN DAVID EMERSON Director Purchase · 10% Series D Convertible Preferred Stock +0 4,049,789
2010-04-09 JORDEN DAVID EMERSON Director Purchase · Common Stock +0 4,321,474
2010-02-25 McLoughlin Mark T Director Grant or award · Nonqualified option to purchase common stock +40,000 276,667
2010-02-25 KEITH STEPHEN Director Grant or award · Nonqualified options to purchase common stock +40,000 80,000
2010-02-25 WINZER C ERIC Director Grant or award · Nonqualified option to purchase common stock +40,000 80,000

Page 20 of 22 · 436 trades